| Document Date: 2011-11-14 09:20:42
Open Document File Size: 243,58 KBShare Result on Facebook
City Redmond / / Company ADP / LG / COX / Microsoft Corporation / Smith SA / / Facility GPIIb/IIIa complex / American College of Veterinary Internal Medicine / / IndustryTerm Chemical inhibitors / / MedicalCondition specific diseases / protein-losing enteropathy / arterial thrombosis / DF / hemolytic anemia / neoplasia / cardiac disease / hypertension / cardiomyopathy / arterial thromboembolism / disease / atherosclerosis / hyperadrenocorticism / vascular endothelial injury / HYPERCOAGULATION AND THROMBOSIS Thrombosis / venous thrombosis / occlusive thrombus / tissue injury / neutropenia / stroke / thrombotic thrombocytopenic purpura / dirofilariasis / hypercoagulability / systemic hypertension / chronic administration / pulmonary lesions / systemic disease / Nephrotic syndrome / severe pancreatitis / injury / inflammatory cytokines / diabetes mellitus / pancreatitis / endocarditis / cardiac disease / thrombus / naturally-occurring hyperadrenocorticism / thrombosis / pathologic thrombosis / sepsis / hypercortisolism / dehydration / / MedicalTreatment thrombolytic therapy / catheterization / surgery / / OperatingSystem Microsoft Windows / / Organization Am Vet Med Assoc / the American College / Am Anim Hosp Assoc / / Person Susan G. Hackner / / Position author / candidate for prophylaxis / / Product Ibuprofen / Microsoft Corporation Portable Audio Device / clopidogrel / adenosine / / ProvinceOrState Washington / / Technology Alpha / antibodies / /
SocialTag |
ANTIPLATELET DRUGS: WHAT, WHEN, AND HOW Susan G. Hackner, BVSc, MRCVS, DACVIM, DACVECC INTRODUCTION Platelets are vital components of normal hemostasis and key participants in pathologic thrombosis by virtue of their abi